RedCarpetLife
1928
In the world today
Alexey Repik

Alexey Repik

A. Repik
-5.76% | - $-131.58M
$2.15 B ₹ 19,582 Cr
Real Time Net Worth #1928 Ranking as of 21 Feb 2026 By Forbes

More on Alexey Repik

Gender

Male

Age

46Y

Country

Russia

Born On

August, 1979

Deceased

No

Relationship Status

Married

Children

3

Education

Unknown

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Pharmaceuticals)

Primary Organization

R-Pharm

Titles

Founder & Chairman

Sources of Wealth

R-Pharm

Industry

Pharmaceuticals, Healthcare

About Alexey Repik


A lexey Repik is a Russian entrepreneur who founded and owns R-Pharm, one of Russia's largest pharmaceutical companies. He started his career in healthcare in the 1990s and founded R-Pharm in 2001. The company began as a distributor of drugs for other manufacturers, but Repik strategically pivoted the business towards manufacturing its own pharmaceuticals.

R-Pharm has become a major producer of a wide range of medicines, including high-tech cancer drugs and, more recently, Covid-19 treatments and vaccines. The company has been a significant beneficiary of the Russian government's import substitution program, which aims to boost domestic production of critical goods, including pharmaceuticals. R-Pharm is a major supplier to the Russian state healthcare system, securing large government contracts that have fueled its rapid growth. Repik has become one of the most influential figures in Russia's pharmaceutical industry.

Advertisement

Quick Reads


  • Founder and owner of R-Pharm, a leading Russian pharmaceutical company.
  • Founded the company in 2001, initially as a drug distributor.
  • Transformed R-Pharm into a major manufacturer of pharmaceuticals, including cancer drugs.
  • A key supplier to the Russian government's healthcare system.
  • Benefited from Russia's import substitution policies in the healthcare sector.

Early Life and Background


Alexey Evgenievich Repik, born on August 27, 1979, in Moscow, Russia, is a self-made pharmaceutical billionaire and founder of the R-Pharm group. His path to entrepreneurship began young and was immediately focused on the healthcare sector.

His educational journey was unique: he only formally enrolled in university after his business was established, graduating from the Higher School of Economics (HSE) with a degree in economics in 2002. His entrepreneurial career began at the age of 22, in 2001, when he founded R-Pharm with a startup capital of just '$40,000', with nearly half borrowed from his mother. His first breakthrough came from leveraging his knowledge of English and Western business conduct to approach foreign pharmaceutical companies.

Career Journey of Alexey Repik


Alexey Repik’s professional life is a story of relentless political and industrial integration. He founded R-Pharm in 2001 as a pharmaceutical distribution company. The company grew rapidly, gaining significant market share by supplying essential medicines to Russia's federal programs. Within four years, R-Pharm had surpassed his previous employer in sales, becoming the dominant business in his life.

His career is marked by securing major state contracts—a crucial factor in his wealth growth, earning him a rank among Forbes' 'Kings of the state order'. He strategically positioned R-Pharm as a vertically integrated international company, investing heavily in R&D, infrastructure (including acquiring a technology center in Bavaria), and securing partnerships with global giants like AstraZeneca (for COVID-19 vaccine production) and Mitsui. His final major strategic move was the sale of his stake in R-Pharm in 2022 to the company's management to protect the firm from international sanctions.

Advertisement

Alexey Repik's Timeline


2001:

Founded R-Pharm at the age of 22 with $40,000 in startup capital.

2002:

Graduated from the Higher School of Economics (HSE).

2007:

R-Pharm surpassed his previous employer in sales.

2017:

Mitsui acquired a 10% stake in R-Pharm for $200 million.

2019 (Oct):

Elected Chairman of the all-Russian public organization 'Delovaya Rossiya'.

2022 (Aug):

Sold his stake in R-Pharm to management to protect the company from sanctions.

2025 (Sept):

Consolidated 100% ownership of the drug retailer EApteka.

Ongoing:

Subject to sanctions by the EU, UK, and US due to his association with the Russian regime.

Major Business Ventures and Investments


Alexey Repik’s wealth is generated from his founding of R-Pharm Group and his subsequent activities as a politically connected industrialist and investor.

  • R-Pharm (Founder): A major Russian pharmaceutical company specializing in the production of finished dosage forms, active pharmaceutical ingredients, and biotechnological substances. It gained international recognition for producing the COVID-19 drug 'Coronavir' and securing a license for the AstraZeneca vaccine.
  • 'Delovaya Rossiya' ('Business Russia'): He is the Co-chairman of this powerful public organization uniting over 7,000 entrepreneurs, giving him immense political and industrial influence.
  • EApteka: Through his structures, he consolidated 100% ownership of this large online retailer and drug delivery service in 2025.
  • R-Stroy: A construction company linked to Repik, founded in 2022, which quickly began building residential and civil infrastructure in the occupied city of Mariupol.

Advertisement

Philanthropy and Social Impact


Alexey Repik has been actively involved in social and philanthropic work for many years, often funding initiatives alongside the Russian Orthodox Church and focusing on entrepreneurship.

  • 'Quench My Griefs' Charitable Foundation: Co-founded with the Russian Orthodox Church, this foundation supports various community causes.
  • Youth Entrepreneurial Initiative Foundation: He founded this initiative to foster the next generation of Russian entrepreneurs.
  • Animal Welfare: He is a major donor to animal causes, currently funding the construction of a large shelter for 1,500 dogs per year in Yaroslavl.

His broader civic role is as a 'public ombudsman' and co-chairman of business and industry councils, actively shaping national strategy under the President's Council for Strategic Development.

Fashion, Style, and Lifestyle


Advertisement

Quotes and Philosophy


“We shouldn't be afraid to admit when we aren't yet capable of doing something.”

“The main thing in business, the main thing in work and the main thing in the economy is a team, these are people and they need to be trained, they need to be raised, they need to be motivated, they need to be preserved.”

Fun Facts & Trivia


  • He started R-Pharm with just '$40,000', half of which he borrowed from his mother.
  • He owns a '$19.1 million mansion in San Francisco' and his children were born in the US.
  • His company, R-Stroy, is one of the main developers constructing infrastructure in the occupied city of Mariupol.
  • He was involved in manufacturing the AstraZeneca COVID-19 vaccine and producing the COVID-19 drug 'Coronavir' in Russia.
  • He is an authorized representative of Vladimir Putin in the non-competitive presidential election.
  • He strategically sold his R-Pharm stake to management in 2022 to protect the company from international sanctions.
  • He is funding the construction of a large 'shelter for 1,500 dogs' in Yaroslavl.

Advertisement

More Profiles


Uday Kotak

-0.34% | -$50.35M

Chen Jiancheng

-0.14% | -$5.07M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content